Search

You searched for "neuroretinopathy"

529 results found

Detecting apoptosis in retinal cells

1 February 2022 | | EYE - Vitreo-Retinal | Apoptosis, Glaucoma, Imaging, Neurodegeneration, Retina
This is a review paper in which the authors summarise the transitioning of techniques detecting apoptosis from bench to bedside, along with the future possibilities they encase. Detection of Apoptosis in Retinal Cells (DARC) technology can be used as a...

New UK study finds widespread hidden sensory loss

20 October 2025 | The College of Optometrists, funding, eye health, optometry, sensory loss
One in four over-50s has vision impairment and three quarters have some hearing loss. Groundbreaking research involving eye tests and hearing examinations with more than 500 over-50’s – the first of its kind in the UK – has revealed widespread...

Appeal for fundus cameras and OCT machines for Nigeria

29 January 2021
Nigeria has the highest population of people living with diabetes mellitus (DM) in sub-Saharan Africa. As at 2013 the population of people living with DM stood at 4.9 million, of whom an estimated 1.7 million had diabetic retinopathy (DR). There is currently no national DR screening and treatment programme.

PREVIEW: RCOphth Annual Congress 2025 #EyeConUK

19 May 2025 | | RCOphth, RCOphth 2025, Annual Congress, EyeConUK, Events, Meetings, Royal College of Ophthalmologists
That time of year is coming around again and the ophthalmic community are ironing their ties and polishing their shoes ready for the Royal College of Ophthalmologists’ Annual #EyeConUK Congress 2025, taking place at the ACC, Liverpool, between 19–22 May....

The screening and treatment of retinopathy of prematurity

1 December 2013 | | EYE - Paediatrics, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
A male child is born at 31 weeks and requires 100% oxygen supplementation with intensive care. What would be the ophthalmic management of this child? In the first instance, it will be useful to know the screening criteria and protocol....

High-stakes scenarios in retinal vein occlusion: A survey of medico-legal implications

2 October 2025 | | EYE - Vitreo-Retinal, EYE - Glaucoma
Central retinal vein occlusion (CRVO) is the second most common retinal vascular disease after diabetic retinopathy, and its clinical complexity often intersects with medico-legal scrutiny [1]. Missteps in timely diagnosis, inadequate follow-up or poor documentation can lead to patient harm...

Shedding light on Wolfram syndrome: The unveiling of a delayed diagnosis

12 August 2025 | | EYE - Neuro-ophthalmology
Wolfram syndrome 1 (WS1) was first described by Wolfram and Wagener in 1938 and it’s a rare neurodegenerative, progressive disorder, also known as DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness) [1]. We present an atypical case of WS...

Cataract incidence rates in patients from the UK suffering with diabetes mellitus

1 October 2018 | | EYE - Cataract, EYE - Refractive, EYE - General
The authors summarise the main findings from a recent study which investigated the incidence rates of cataract in patients with or without diabetes mellitus (DM). Background to the study Worldwide, the World Health Organization (WHO) estimates that 253 million people...

The Leicester Grading System for Foveal Hypoplasia

1 April 2020 | | EYE - Paediatrics, EYE - Neuro-ophthalmology, EYE - Orbit, EYE - General
The University of Leicester Ulverscroft Eye Unit have published the first medical grading system named after the city of Leicester. Infantile nystagmus is characterised by constant and involuntary eye movements and affects 24 per 10,000 people [1]. Onset is usually...

Ophthalmology assessment using Revised Bloom’s Taxonomy

1 December 2020 | | EYE - General
Bloom’s Taxonomy is a hierarchical list of attributes and skills that facilitates teachers to effectively teach, whilst concurrently enabling learners to effectively learn. It was first developed in 1956 by Benjamin Bloom, an educational psychologist along with a team of...

Semaglutide and vision loss: A new concern for NAION risk?

4 December 2025 | | EYE - Neuro-ophthalmology
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as transformative agents in...

Eye Capacity: clinical need should drive ophthalmic service provision

1 February 2014 |
Almost two million people in the UK suffer sight loss, a number forecast to double over coming decades. Major causes of blindness are age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, cataract and uncorrected refractive error. Prevalence of these sight-threatening conditions...